These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2905363

  • 41. The value of anti-anxiety drugs in the management of cardiac disease.
    Wheatley D.
    Acta Med Scand Suppl; 1982; 660():219-30. PubMed ID: 6127907
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Patient acceptance as a factor in the effectiveness of treatment: an open assessment of potassium clorazepate ('Tranxene') and lorazepam in anxiety.
    Harris PG.
    Curr Med Res Opin; 1982; 2(10):664-8. PubMed ID: 4156290
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effects of clorazepate dipotassium and placebo on psychomotor skills.
    Moodley P, Golombok S, Lader M.
    Percept Mot Skills; 1985 Dec; 61(3 Pt 2):1121-2. PubMed ID: 2869470
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Tranxene.
    Csillag ER.
    Med J Aust; 1977 Aug 06; 2(6):196. PubMed ID: 20558
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Preoperative anxiolysis with minimal sedation in elderly patients: bromazepam or clorazepate-dipotassium?
    Erb T, Sluga M, Hampl KF, Ummenhofer W, Schneider MC.
    Acta Anaesthesiol Scand; 1998 Jan 06; 42(1):97-101. PubMed ID: 9527752
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Clorazepat in the treatment of anxiety-depression syndroms in neuroses.
    Florkowski A, Kocur J, Rydzynski Z, Duszyk S, Trendak W, Gruszczyński W.
    Act Nerv Super (Praha); 1989 Apr 06; 31(1):26-7. PubMed ID: 2571217
    [No Abstract] [Full Text] [Related]

  • 53. [The use of spitomine (buspirone) in the combined therapy of panic disorder].
    Vasileva AV, Karavaeva TA, Poltorak SV, Chekhlaty EI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Apr 06; 115(11):63-71. PubMed ID: 26978053
    [Abstract] [Full Text] [Related]

  • 54. Effects of clorazepate, diazepam, and oxazepam on a laboratory measurement of aggression in men.
    Weisman AM, Berman ME, Taylor SP.
    Int Clin Psychopharmacol; 1998 Jul 06; 13(4):183-8. PubMed ID: 9727729
    [Abstract] [Full Text] [Related]

  • 55. Delusional misidentification of the Capgras and intermetamorphosis types responding to clorazepate. A case report.
    Joseph AB.
    Acta Psychiatr Scand; 1987 Mar 06; 75(3):330-2. PubMed ID: 2884809
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Change from zolpidem to clorazepate won't solve the patient's problem.
    Davis NH.
    Am J Health Syst Pharm; 1997 Mar 01; 54(5):588. PubMed ID: 9066874
    [No Abstract] [Full Text] [Related]

  • 60. [The use of chlorazepate dipotassium (Tranxene) in the states of restlessness and agitation].
    Kiejna A, Kantorska-Janiec M, Małyszczak K.
    Psychiatr Pol; 1997 Mar 01; 31(6):753-60. PubMed ID: 9515307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.